GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 38 filers reported holding GALERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140 | -99.3% | 800 | -86.9% | 0.00% | – |
| Q2 2023 | $19,057 | +331.1% | 6,108 | +253.7% | 0.00% | – |
| Q1 2023 | $4,421 | +208.9% | 1,727 | +79.9% | 0.00% | – |
| Q4 2022 | $1,431 | -28.4% | 960 | +6.7% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 900 | -69.2% | 0.00% | – |
| Q2 2022 | $3,000 | -75.0% | 2,919 | -39.5% | 0.00% | – |
| Q1 2022 | $12,000 | -82.1% | 4,826 | -66.8% | 0.00% | – |
| Q4 2021 | $67,000 | -56.5% | 14,544 | -23.1% | 0.00% | – |
| Q3 2021 | $154,000 | -37.7% | 18,923 | -24.7% | 0.00% | – |
| Q2 2021 | $247,000 | +22.3% | 25,144 | +9.7% | 0.00% | – |
| Q1 2021 | $202,000 | -30.6% | 22,925 | -19.3% | 0.00% | – |
| Q4 2020 | $291,000 | +142.5% | 28,417 | +114.2% | 0.00% | – |
| Q3 2020 | $120,000 | +73.9% | 13,267 | +36.3% | 0.00% | – |
| Q2 2020 | $69,000 | +122.6% | 9,737 | +206.0% | 0.00% | – |
| Q1 2020 | $31,000 | +93.8% | 3,182 | +163.2% | 0.00% | – |
| Q4 2019 | $16,000 | – | 1,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
| Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
| NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
| SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
| RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
| Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
| Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
| Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
| Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |